Prostate Cancer - Results from #900

Contemporary Diagnosis of Very Low-risk Prostate Cancer in a Multihospital Health Care System. May 14, 2024

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis. May 14, 2024

ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth and constrain ferroptosis. May 14, 2024

High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue. May 14, 2024

Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data Set. May 14, 2024

Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy. May 14, 2024

MRI assessment of seminal vesicle involvement by prostate cancer using T2 signal intensity and volume. May 14, 2024

Overall survival benefit of androgen suppression in addition to dose-escalated external beam radiotherapy for high-risk prostate cancer: Nationwide real-world data indicates a shift in men that benefit. May 13, 2024

Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection. May 13, 2024

Applications of wearable activity monitors for prostate cancer survivors: A systematic scoping review. May 13, 2024

Perioperative, Oncological and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial. May 13, 2024

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer. May 13, 2024

Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomes. May 13, 2024

Defining oligometastatic state in uro-oncological cancers. May 10, 2024

Prostate Cancer Incidence and Mortality in Men Exposed to α1-Adrenoceptor Antagonists. May 10, 2024

A Model for Predicting Clinically Significant Prostate Cancer using Prostate MRI and Risk Factors. May 10, 2024

The association between neighborhood obesogenic factors and prostate cancer risk and mortality: the Southern Community Cohort Study. May 10, 2024

Prostate biopsy sepsis prevention: external validation of an alcohol needle washing protocol. May 10, 2024

A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer. May 10, 2024

Salivary excretion of systemically injected [18F]DCFPyL in prostate cancer patients undergoing PSMA scans. May 9, 2024

Page 46 of 1436